Lybrate operates a platform to connect patients with doctors in India and offers services including remote doctor-patient consultations, patient management tools for clinicians, and at-home lab sample collection via Lybrate Lab+. The company reports over 100,000 verified doctors on its platform, more than six million monthly “interactions” (searches, health queries, or communications), and 4.5 million app downloads. Lybrate says it is seeing traction in India’s second- and third-tier cities and is planning new language options to reach more rural users. Its Lab+ service is active in Delhi, Mumbai and Bangalore. The company was founded in 2013 and is incorporated in the U.S. Financially, Lybrate has raised incremental capital over time and recently filed a U.S. disclosure for new funding. Lybrate is a New Delhi–based medical service that connects patients with doctors via a web platform and Android/iOS apps. Users can post questions (anonymously if desired), search nearby doctors and clinics, book and manage appointments, and store patient records. The platform handles one-on-one consultations—allowing users to share photos, videos, and chat—and charges a variable fee set by doctors plus an internet handling fee typically of 5–15 percent. Lybrate also provides Facebook-like feeds with tailored daily health tips for groups such as pregnant women and the elderly. The company reports more than 80,000 doctors on the platform, over 100,000 daily visitors, and its mobile apps have been downloaded over half a million times since launching in January. It plans to use new funding to hire staff, develop its technology, and scale to reach more doctors and patients across India. Lybrate operates an online directory and booking platform for doctors in India. Founded in 2013, the company sits among international peers such as KelDoc, DocPlanner, Zesty and U.S. rival ZocDoc. According to app‑tracking site App Annie, Lybrate ranks among the top 400 medical apps on Google Play in the region. The service has an early lead in India but the market shows room for outside competition, including potential entrants from ZocDoc. Financially, Lybrate disclosed a raise of $1.23 million in a public SEC filing and said the total may increase to $1.33 million. The company’s future competitive position will depend on how it responds to incoming international competitors and any further fundraising activity.

Total raised

$14M

Funding rounds

3

Latest round

Equity

Latest activity

Apr 2017